Feob-mediated uptake of iron by francisella tularensis

Infection and Immunity

Volumn 81, Issue 8, 2013, Pages 2828-2837

  Thomas Charles, Cindy A ^a   Zheng, Huaixin ^a,b   Palmer, Lance E ^a,c   Mena, Patricio ^a   Thanassi, David G ^a   Furie, Martha B ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS ION; PROTEIN FEOB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; EPITHELIUM CELL; FETUS; FRANCISELLA TULARENSIS; GENE DELETION; GENE MUTATION; IRON TRANSPORT; LETHAL DOSE; LIVER; LIVER CELL; LUNG; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SPLEEN;

ANIMALS; CATION TRANSPORT PROTEINS; CELL LINE; DISEASE MODELS, ANIMAL; FRANCISELLA TULARENSIS; HEPATOCYTES; HUMANS; IRON; MACROPHAGES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TULAREMIA; VIRULENCE;

EID: 84880653318     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00170-13     Document Type: Article

References (59)

1. Tärnvik A, Berglund L. 2003. Tularaemia. Eur. Respir. J. 21:361-373.
2. Ellis J, Oyston PCF, Green M, Titball RW. 2002. Tularemia. Clin. Microbiol. Rev. 15:631-646.
3. Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S. 1961. Tularemia vaccine study. II. Respiratory challenge. Arch. Intern. Med. 107: 702-714.
4. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O′Toole T, Parker G, Perl TM, Russell PK, Tonat K. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285:2763-2773.
5. Fortier AH, Slayter MV, Ziemba R, Meltzer MS, Nacy CA. 1991. Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59:2922-2928.
6. Conlan JW, North RJ. 1992. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect. Immun. 60:5164-5171.
7. Bolger CE, Forestal CA, Italo JK, Benach JL, Furie MB. 2005. The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflamma-tory cytokines. J. Leukoc. Biol. 77:893-897.
8. Bosio CM, Dow SW. 2005. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175:6792-6801.
9. Qin A, Mann BJ. 2006. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol. 6:69. doi:10.1186/1471-2180-6-69.
10. Rasmussen JW, Cello J, Gil H, Forestal CA, Furie MB, Thanassi DG, Benach JL. 2006. Mac-1+ cells are the predominant subset in the early hepatic lesions of mice infected with Francisella tularensis. Infect. Immun. 74:6590-6598.
11. Hall JD, Craven RR, Fuller JR, Pickles RJ, Kawula TH. 2007. Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation. Infect. Immun. 75:1034-1039.
12. Wickstrum JR, Bokhari SM, Fischer JL, Pinson DM, Yeh HW, Horvat RT, Parmely MJ. 2009. Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice. Infect. Immun. 77:4827-4836.
13. Pan X, Tamilselvam B, Hansen EJ, Daefler S. 2010. Modulation of iron homeostasis in macrophages by bacterial intracellular pathogens. BMC Microbiol. 10:64. doi :10.1186/1471-2180-10-64.
14. Ray HJ, Chu P, Wu TH, Lyons CR, Murthy AK, Guentzel MN, Klose KE, Arulanandam BP. 2010. The Fischer 344 rat reflects human susceptibility to Francisella pulmonary challenge and provides a new platform for virulence and protection studies. PLoS One 5:e9952. doi:10.1371/journal.pone.0009952.
15. Tresselt HB, Ward MK. 1964. Blood-free medium for the rapid growth of Pasteurella tularensis. Appl. Microbiol. 12:504-507.
16. Lenco J, Hubalek M, Larsson P, Fucikova A, Brychta M, Macela A, Stulik J. 2007. Proteomics analysis of the Francisella tularensis LVS response to iron restriction: induction of the F. tularensis pathogenicity island proteins IglABC. FEMS Microbiol. Lett. 269:11-21.
17. Nano FE, Schmerk C. 2007. The Francisella pathogenicity island. Ann. N. Y. Acad. Sci. 1105:122-137.
18. Deng K, Blick RJ, Liu W, Hansen EJ. 2006. Identification of Francisella tularensisgenes affectedbyiron limitation. Infect. Immun. 74:4224-4236.
19. Lindgren H, Honn M, Salomonsson E, Kuoppa K, Forsberg A, Sjöstedt A. 2011. Iron content differs between Francisella tularensis subspecies tularensis and subspecies holarctica strains and correlates to their susceptibility to H2O2-induced killing. Infect. Immun. 79:1218-1224.
20. Andrews SC, Robinson AK, Rodriguez-Quinones F. 2003. Bacterial iron homeostasis. FEMS Microbiol. Rev. 27:215-237.
21. Sullivan JT, Jeffery EF, Shannon JD, Ramakrishnan G. 2006. Characterization of the siderophore of Francisella tularensis and role of fslA in siderophore production. J. Bacteriol. 188:3785-3795.
22. Kiss K, Liu W, Huntley JF, Norgard MV, Hansen EJ. 2008. Characterization of fig operon mutants of Francisella novicida U112. FEMS Micro-biol. Lett. 285:270-277.
23. Ramakrishnan G, Meeker A, Dragulev B. 2008. fslE is necessary for siderophore-mediated iron acquisition in Francisella tularensis Schu S4. J. Bacteriol. 190:5353-5361.
24. Hantke K. 2003. Is the bacterial ferrous iron transporter FeoB a living fossil? Trends Microbiol. 11:192-195.
25. Kammler M, Schon C, Hantke K. 1993. Characterization of the ferrous iron uptake system of Escherichia coli. J. Bacteriol. 175:6212-6219.
26. Velayudhan J, Hughes NJ, McColm AA, Bagshaw J, Clayton CL, Andrews SC, Kelly DJ. 2000. Iron acquisition and virulence in Helicobacter pylori: a major role for FeoB, a high-affinity ferrous iron transporter. Mol. Microbiol. 37:274-286.
27. Naikare H, Palyada K, Panciera R, Marlow D, Stintzi A. 2006. Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect. Immun. 74:5433-5444.
28. Perry RD, Mier I, Jr, Fetherston JD. 2007. Roles of the Yfe and Feo transporters of Yersinia pestis in iron uptake and intracellular growth. Biometals 20:699-703.
29. Cartron ML, Maddocks S, Gillingham P, Craven CJ, Andrews SC. 2006. Feo-transport of ferrous iron into bacteria. Biometals 19:143-157.
30. Su J, Yang J, Zhao D, Kawula TH, Banas JA, Zhang JR. 2007. Genome-wide identification of Francisella tularensis virulence determinants. Infect. Immun. 75:3089-3101.
31. Conlan JW, Chen W, Shen H, Webb A, Kuo Lee R. 2003. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb. Pathog. 34:239-248.
32. Wickstrum JR, Hong KJ, Bokhari S, Reed N, McWilliams N, Horvat RT, Parmely MJ. 2007. Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis. Infect. Immun. 75: 1335-1342.
33. Collazo CM, Meierovics AI, De PR, Wu TH, Lyons CR, Elkins KL. 2009. T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria. Infect. Immun. 77:2010-2021.
34. Bokhari SM, Kim KJ, Pinson DM, Slusser J, Yeh HW, Parmely MJ. 2008. NK cells and gamma interferon coordinate the formation and function of hepatic granulomas in mice infected with the Francisella tularensis live vaccine strain. Infect. Immun. 76:1379-1389.
35. Gao B, Jeong WI, Tian Z. 2008. Liver: an organ with predominant innate immunity. Hepatology 47:729-736.
36. Noah CE, Malik M, Bublitz DC, Camenares D, Sellati TJ, Benach JL, Furie MB. 2010. GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages. Infect. Im-mun. 78:1797-1806.
37. Breslow JL, Sloan HR, Ferrans VJ, Anderson JL, Levy RI. 1973. Characterization of the mouse liver cell line FL83B. Exp. Cell Res. 78:441-453.
38. Wu JC, Merlino G, Fausto N. 1994. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc. Natl. Acad. Sci. U. S. A. 91:674-678.
39. Yan W, Lee H, Deutsch EW, Lazaro CA, Tang W, Chen E, Fausto N, Katze MG, Aebersold R. 2004. A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry. Mol. Cell. Proteomics 3:1039-1041.
40. Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW. 2008. An improved vaccine for prevention ofrespiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine 26:5276-5288.
41. PfafflMW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
42. LoVullo ED, Sherrill LA, Perez LL, Pavelka MS, Jr. 2006. Genetic tools for highly pathogenic Francisella tularensis subsp. tularensis. Microbiology 152:3425-3435.
43. LoVullo ED, Molins-Schneekloth CR, Schweizer HP, Pavelka MS, Jr. 2009. Single-copy chromosomal integration systems for Francisella tular- ensis. Microbiology 155:1152-1163.
44. Chamberlain RE. 1965. Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol. 13:232-235.
45. Cherwonogrodzky JW, Knodel MH, Spence MR. 1994. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium. Vaccine 12:773-775.
46. Lindgren H, Honn M, Golovlev I, Kadzhaev K, Conlan W, Sjostedt A. 2009. The 58-kilodalton major virulence factor of Francisella tularensis is required for efficient utilization of iron. Infect. Immun. 77:4429-4436.
47. Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56.
48. Riemer J, Hoepken HH, Czerwinska H, Robinson SR, Dringen R. 2004. Colorimetric ferrozine-based assay for the quantitationof iron in cultured cells. Anal. Biochem. 331:370-375.
49. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30:207-210.
50. Wehrly TD, Chong A, Virtaneva K, Sturdevant DE, Child R, Edwards JA, Brouwer D, Nair V, Fischer ER, Wicke L, Curda AJ, Kupko JJ, Martens IIIC, Crane DD, Bosio CM, Porcella SF, Celli J. 2009. Intra-cellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell Microbiol. 11:1128-1150.
51. Foley JE, Nieto NC. 2010. Tularemia. Vet. Microbiol. 140:332-338.
52. Huntley JF, Conley PG, Hagman KE, Norgard MV. 2007. Characterization of Francisella tularensis outer membrane proteins. J. Bacteriol. 189: 561-574.
53. Sen B, Meeker A, Ramakrishnan G. 2010. The fslE homolog, FTL_0439 (fupA/B), mediates siderophore-dependent iron uptake in Francisella tu-larensis LVS. Infect. Immun. 78:4276-4285.
54. Stojiljkovic I, Cobeljic M, Hantke K. 1993. Escherichia coli K-12 ferrous iron uptake mutants are impaired in their ability to colonize the mouse intestine. FEMS Microbiol. Lett. 108:111-115.
55. Ramakrishnan G, Sen B, Johnson R. 2012. Paralogous outer membrane proteins mediate uptake of different forms of iron and synergistically govern virulence in Francisella tularensis tularensis. J. Biol. Chem. 287:25191-25202.
56. Doherty CP. 2007. Host-pathogen interactions: the role of iron. J. Nutr. 137:1341-1344.
57. Nallaparaju KC, Yu JJ, Rodriguez SA, Zogaj X, Manam S, Guentzel MN, Seshu J, Murthy AK, Chambers JP, Klose KE, Arulanandam BP. 2011. Evasion of IFN-gamma signaling by Francisella novicida is dependent upon Francisella outer membrane protein C. PLoS One 6:e18201. doi: 10.1371/journal.pone.0018201.
58. Sjöstedt A. 2007. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann. N. Y. Acad. Sci. 1105:1-29.
59. Forestal CA, Malik M, Catlett SV, Savitt AG, Benach JL, Sellati TJ, Furie MB. 2007. Francisella tularensis has a significant extracellular phase in infected mice. J. Infect. Dis. 196:134-137.